Background: Vitamin D seems to influence the evolution of atopic dermatitis (AD) in children. Methods: We tested the vitamin D serum levels of 39 children with AD (AD group t₀) and of 20 nonallergic healthy controls (C group). AD severity was evaluated using the AD scoring system (SCORAD index). Cytokine serum levels (IL-2, IL-4, IL-6, IFN-γ, TNF-α) and atopy biomarkers were also measured. The patients were then treated with vitamin D oral supplementation of 1,000 IU/day (25 mg/day) for 3 months. We then reevaluated the vitamin D serum levels, AD severity and cytokine serum levels in all of the treated children (AD group t1). Results: The cross-sectional analysis on patients affected by AD (AD group t₀) showed that the initial levels of all the tested cytokines except for TNF-α were higher than those of the healthy control group (C group), falling outside the normal range. After 3 months of supplementation the patients had significantly increased vitamin D levels (from 22.97 ± 8.03 to 29.41 ± 10.73 ng/ml; p = 0.01). A concomitant significant reduction of both the SCORAD index (46.13 ± 15.68 at the first visit vs. 22.57 ± 15.28 at the second visit; p < 0.001) and of all the altered cytokines (IL-2, IL-4, IL-6, IFN-γ) was also found. Conclusions: This study showed vitamin D supplementation to be an effective treatment in reducing AD severity in children through normalization of the Th1 and Th2 interleukin serum pattern.

1.
Novak N, Simon D: Atopic dermatitis - from new pathophysiologic insights to individualized therapy. Allergy 2011;66:830-839.
2.
Bieber T: Atopic dermatitis. New Engl J Med 2008;358:1483-1494.
3.
Dogru M, Kirmizibekmez H, Yesiltepe Mutlu RG, Aktas A, Ozturkmen S: Clinical effects of vitamin D in children with asthma. Int Arch Allergy Immunol 2014;164:319-325.
4.
Wjst M, Dold S: Genes, factor X, and allergens: what causes allergic diseases? Allergy 1999;54:757-759.
5.
Back O, Blomquist HK, Hernell O, et al: Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 2009;89:28-32.
6.
Erkkola M, Kaila M, Nwaru BI, et al: Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy 2009;39:875-882.
7.
Miyake Y, Sasaki S, Tanaka K, et al: Dairy food, calcium, and vitamin D intake in pregnancy and wheeze and eczema in infants. Eur Respir J 2010;35:1228-1234.
8.
Willers SM, Devereux G, Craig LC, et al: Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 2007;62:773-779.
9.
Peroni DG, Piacentini E, Cametti E, et al: Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Brit J Dermatol 2011;164:1078-1082.
10.
Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, et al: Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 2012;11:327-330.
11.
Searing DA, Leung DY: Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin 2010;30:397-409.
12.
Antal S, Dombrowski Y, Koglin S, et al: Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol 2011;3:18-22.
13.
Bikle DD: Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008;17:348-352.
14.
Rausch-Fan X, Leutmezer F, Willheim M, Spittler A, Bohle B, Ebner C, Jensen-Jarolim E, Boltz-Nitulescu G: Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific Th cell clones by 1α,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 2002;128:33-41.
15.
Oranje AP, Glazenburg EJ, Wolkerstorfer A, et al: Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Brit J Dermatol 2007;157:645-648.
16.
Stadler JF, Taieb A: Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
17.
Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
18.
Eichenfield LF, Ellis CN, Mancini AJ, Paller AS, Simpson EL: Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg 2012;31:S3-S5.
19.
Boguniewicz M, Leung DY: Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242:233-246.
20.
Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al: Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol 2013;131:295-299.
21.
Hamid Q, Boguniewicz M, Leung DY: Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-876.
22.
Brandt EB, Sivaprasad U: Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2011; 2:110.
23.
Miller J, Gallo RL: Vitamin D and innate immunity. Dermatol Ther 2010;23:13-22.
24.
Mutgi K, Koo J: Update on the role of systemic vitamin D in atopic dermatitis. Pediatr Dermatol 2013;30:303-307.
25.
Brehm JM, Celedon C, Soto-Quiros ME, Avila L, et al: Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care 2009;179:765-771.
26.
Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
27.
Abbas AK, Lichtman AH: Fondamenti di immunologia. Funzioni e alterazioni del sistema immunitario. Padova, Piccin Nuova Libraria, 2003, pp 295-309.
28.
Seltmann J, Werfel T, Wittmann M: Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation. Exp Dermatol 2013;22:102-107.
29.
Rebane A, Zimmermann M, Aab A, et al: Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol 2012;129:1297-1306.
30.
Schwalfenberg GK: A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011;55:96-108.
31.
Alitalo A: Human anti-infectious defence may be enhanced by vitamin D (in Finnish). Duodecim 2010;126:1127-1134.
32.
Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB, Peiris AN: Antimicrobial implications of vitamin D. Dermatoendocrinol 2011;3:220-229.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.